Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasmapheresis for Long-haul COVID
NCT05543590Withdrawn
- Sponsor
- Hôpital Européen Marseille
- Start
- Feb 2023
- Primary completion
- Feb 2025
01
Overview
Randomised, open-label trial (2 arms), sponsored by Hôpital Européen Marseille. Primary endpoint: Percentage of patients whose fatigue has decreased by 30% on the Chalder scale at 3 months. Planned start Feb 2023; status: withdrawn.
Beyond the preview
Go deeper on NCT05543590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05543590.